Product Code: ETC416442 | Publication Date: Jul 2023 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Hydromorphone is a potent opioid analgesic used for the management of moderate to severe pain. It belongs to the class of drugs known as opioid agonists and is prescribed in various forms, including oral tablets, injectable formulations, and extended-release formulations.
Pain Management: The primary driver for the use of hydromorphone is its effectiveness in managing moderate to severe pain. The demand for hydromorphone may be driven by factors such as increasing prevalence of chronic pain conditions, aging populations, and surgical procedures. Medical Applications: Hydromorphone is used in medical settings, including hospitals and palliative care centers, for pain relief in acute and chronic conditions, such as cancer pain or post-surgical pain. Pharmaceutical Industry: The demand for hydromorphone is influenced by the pharmaceutical industry`s focus on developing effective pain management medications and meeting the needs of patients who do not respond well to other analgesics. Regulatory Framework: The availability and use of hydromorphone are regulated by national health authorities and healthcare professionals to ensure appropriate prescribing, dispensing, and patient monitoring practices.
Risk of Abuse and Addiction: Hydromorphone, like other opioid analgesics, carries a risk of abuse, addiction, and dependence. Strict control measures and monitoring are required to minimize these risks and ensure responsible use. Safety Concerns and Side Effects: The use of hydromorphone can be associated with various side effects, including respiratory depression, sedation, and gastrointestinal disturbances. Proper patient selection, dosage adjustment, and monitoring are essential to ensure patient safety. Regulatory Constraints: Regulatory guidelines and restrictions related to the prescribing, dispensing, and storage of hydromorphone can present challenges for healthcare providers and patients in accessing the medication. Opioid Epidemic: The global opioid epidemic, characterized by the misuse, addiction, and overdose of opioids, has prompted increased scrutiny and control measures for opioid medications, including hydromorphone. Alternatives and Non-Opioid Pain Management: The growing interest in non-opioid pain management approaches and alternative analgesics may impact the market demand for hydromorphone.
The COVID-19 pandemic has had diverse effects on different industries. While the specific impact on the Jordan hydromorphone market from 2023 to 2029 cannot be determined without real-time data, the pandemic may have influenced healthcare systems, prescribing practices, and patient access to pain management medications. Disruptions in healthcare services, changes in patient behavior, and supply chain challenges may have affected the market dynamics of hydromorphone.
Key players in the Jordan Hydromorphone Market may have a presence in Jordan. Some well-known companies in the pharmaceutical industry that manufacture hydromorphone include: Mallinckrodt Pharmaceuticals, Purdue Pharma, Pfizer Inc., Hikma Pharmaceuticals, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Mylan N.V.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Hydromorphone Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Hydromorphone Market Revenues & Volume, 2021 & 2028F |
3.3 Jordan Hydromorphone Market - Industry Life Cycle |
3.4 Jordan Hydromorphone Market - Porter's Five Forces |
3.5 Jordan Hydromorphone Market Revenues & Volume Share, By Type, 2021 & 2028F |
3.6 Jordan Hydromorphone Market Revenues & Volume Share, By Application, 2021 & 2028F |
4 Jordan Hydromorphone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Jordan Hydromorphone Market Trends |
6 Jordan Hydromorphone Market, By Types |
6.1 Jordan Hydromorphone Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Hydromorphone Market Revenues & Volume, By Type, 2018 - 2028F |
6.1.3 Jordan Hydromorphone Market Revenues & Volume, By Oral, 2018 - 2028F |
6.1.4 Jordan Hydromorphone Market Revenues & Volume, By Injection, 2018 - 2028F |
6.2 Jordan Hydromorphone Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Jordan Hydromorphone Market Revenues & Volume, By Hospital, 2018 - 2028F |
6.2.3 Jordan Hydromorphone Market Revenues & Volume, By Drug Store, 2018 - 2028F |
7 Jordan Hydromorphone Market Import-Export Trade Statistics |
7.1 Jordan Hydromorphone Market Export to Major Countries |
7.2 Jordan Hydromorphone Market Imports from Major Countries |
8 Jordan Hydromorphone Market Key Performance Indicators |
9 Jordan Hydromorphone Market - Opportunity Assessment |
9.1 Jordan Hydromorphone Market Opportunity Assessment, By Type, 2021 & 2028F |
9.2 Jordan Hydromorphone Market Opportunity Assessment, By Application, 2021 & 2028F |
10 Jordan Hydromorphone Market - Competitive Landscape |
10.1 Jordan Hydromorphone Market Revenue Share, By Companies, 2021 |
10.2 Jordan Hydromorphone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |